Cassava Sciences Files 8-K on Operations and Finances
Ticker: FLNA · Form: 8-K · Filed: Nov 12, 2025 · CIK: 1069530
| Field | Detail |
|---|---|
| Company | Cassava Sciences INC (FLNA) |
| Form Type | 8-K |
| Filed Date | Nov 12, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting
TL;DR
Cassava Sciences filed an 8-K on Nov 12, 2025, for operations and financials. No specific numbers yet.
AI Summary
Cassava Sciences, Inc. filed an 8-K on November 12, 2025, reporting on its results of operations and financial condition, as well as submitting financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a formal reporting event.
Why It Matters
This filing signifies a routine but important update from Cassava Sciences to the SEC regarding its financial status and operational outcomes, which can influence investor perception.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting event without immediate disclosed material changes or negative news.
Key Players & Entities
- Cassava Sciences, Inc. (company) — Registrant
- November 12, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Austin, Texas (location) — Principal Executive Offices
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided text of the 8-K filing indicates it is for 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but does not contain specific financial figures or operational details within the excerpt.
What is the exact date of the earliest event reported in this 8-K?
The exact date of the earliest event reported is November 12, 2025.
What is Cassava Sciences, Inc.'s state of incorporation?
Cassava Sciences, Inc. is incorporated in Delaware.
Where are Cassava Sciences, Inc.'s principal executive offices located?
Cassava Sciences, Inc.'s principal executive offices are located at 6801 N Capital of Texas Highway, Building 1; Suite 300, Austin, Texas 78731.
What is the Commission File Number for Cassava Sciences, Inc.?
The Commission File Number for Cassava Sciences, Inc. is 001-41905.
Filing Stats: 502 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2025-11-12 08:10:27
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value SAVA NASDAQ Capital Market
Filing Documents
- f8k_111225.htm (8-K) — 15KB
- exh_991.htm (EX-99.1) — 65KB
- 0001171843-25-007222.txt ( ) — 283KB
- gnw-20250101.xsd (EX-101.SCH) — 3KB
- gnw-20250101_def.xml (EX-101.DEF) — 25KB
- gnw-20250101_lab.xml (EX-101.LAB) — 35KB
- gnw-20250101_pre.xml (EX-101.PRE) — 24KB
- f8k_111225_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On November 12, 2025, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information provided in this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit Number Description 99.1 Press Release dated November 12, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cassava Sciences, Inc. a Delaware corporation Date: November 12, 2025 By: /s/ Eric J. Schoen Eric J. Schoen Chief Financial Officer